Proinflammatory cytokines contribute to development and function of regulatory T cells in type 1 diabetes

Annals of the New York Academy of Sciences

Volumn 1283, Issue 1, 2013, Pages 81-86

  Thomas, Helen E ^a,b   Graham, Kate L ^a   Chee, Jonathan ^a   Thomas, Ranjeny ^c   Kay, Thomas W ^a,b   Krishnamurthy, Balasubramanian ^a  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

IL 1; Regulatory T cells; TNF ; Type 1 diabetes

Indexed keywords

CYTOKINE; ETANERCEPT; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 1BETA; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CELL DESTRUCTION; CELL MATURATION; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; LYMPHOCYTE MIGRATION; MOLECULAR PATHOLOGY; NONHUMAN; PANCREAS ISLET BETA CELL; PHASE 2 CLINICAL TRIAL (TOPIC); REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; T LYMPHOCYTE ACTIVATION;

MUS;

EID: 84876796565     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2012.06797.x     Document Type: Article

References (29)

1. Barker, J.M. et al. 2004. Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). J. Clin. Endocrinol. Metab. 89: 3896-3902.
2. Nakayama, M. et al. 2005. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 435: 220-223.
3. Krishnamurthy, B. et al. 2006. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP. J. Clin. Invest. 116: 3258-3265.
4. Coppieters, K.T. et al. 2012. Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J. Exp. Med. 209: 51-60.
5. Rowe, P.A. et al. 2011. The pancreas in human type 1 diabetes. Semin. Immunopathol. 33: 29-43.
6. Bertin-Maghit, S. et al. 2011. Interleukin-1beta produced in response to islet autoantigen presentation differentiates T-helper 17 cells at the expense of regulatory T-cells: implications for the timing of tolerizing immunotherapy. Diabetes 60: 248-257.
7. Thomas, H.E. et al. 2009. Beta cell apoptosis in diabetes. Apoptosis 14: 1389-1404.
8. Chee, J. et al. 2011. TNF receptor 1 deficiency increases regulatory T cell function in nonobese diabetic mice. J. Immunol. 187: 1702-1712.
9. Thomas, H.E. et al. 2004. IL-1 receptor deficiency slows progression to diabetes in the NOD mouse. Diabetes 53: 113-121.
10. Thomas, H.E. et al. 1998. IFN-gamma action on pancreatic beta cells causes class I MHC upregulation but not diabetes. J. Clin. Invest. 102: 1249-1257.
11. Aggarwal, B.B. 2003. Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 3: 745-756.
12. Chen, X. et al. 2007. Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells. J. Immunol. 179: 154-161.
13. Green, E.A. et al. 1998. Local expression of TNF alpha in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens. Immunity 9: 733-743.
14. Lee, L.F. et al. 2005. The role of TNF-alpha in the pathogenesis of type 1 diabetes in the nonobese diabetic mouse: analysis of dendritic cell maturation. Proc. Natl. Acad. Sci. USA 102: 15995-16000.
15. Jacob, C.O. et al. 1990. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. Proc. Natl. Acad. Sci. USA 87: 968-972.
16. Satoh, J. et al. 1989. Recombinant human tumor necrosis factor alpha suppresses autoimmune diabetes in nonobese diabetic mice. J. Clin. Invest. 84: 1345-1348.
17. Zhou, R. et al. 2010. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 11: 136-140.
18. Pfleger, C. et al. 2008. Association of IL-1ra and adiponectin with C-peptide and remission in patients with type 1 diabetes. Diabetes 57: 929-937.
19. Wang, X. et al. 2008. Identification of a molecular signature in human type 1 diabetes mellitus using serum and functional genomics. J. Immunol. 180: 1929-1937.
20. Kagi, D. et al. 1999. TNF receptor 1-dependent beta cell toxicity as an effector pathway in autoimmune diabetes. J. Immunol. 162: 4598-4605.
21. Tang, Q. et al. 2008. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat. Immunol. 9: 239-244.
22. Nadkarni, S. et al. 2007. Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta. J. Exp. Med. 204: 33-39.
23. Valencia, X. et al. 2006. TNF downmodulates the function of human CD4+CD25hi T-regulatory cells. Blood 108: 253-261.
24. Wu, A.J. et al. 2002. Tumor necrosis factor-alpha regulation of CD4+CD25+ T cell levels in NOD mice. Proc. Natl. Acad. Sci. USA 99: 12287-12292.
25. Mastrandrea, L. et al. 2009. Etanercept treatment in children with new-onset type 1 diabetes: pilot randomized, placebo-controlled, double-blind study. Diabetes Care 32: 1244-1249.
26. Kohm, A.P. et al. 2002. Cutting edge: CD4+CD25+regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 169: 4712-4716.
27. Poligone, B. et al. 2002. Elevated NF-kappaB activation in nonobese diabetic mouse dendritic cells results in enhanced APC function. J. Immunol. 168: 188-196.
28. O'Sullivan, B.J. et al. 2006. IL-1 beta breaks tolerance through expansion of CD25+ effector T cells. J. Immunol. 176: 7278-7287.
29. Ablamunits, V. et al. 2012. Synergistic reversal of type 1 diabetes in NOD mice with anti-CD3 and interleukin-1 blockade: evidence of improved immune regulation. Diabetes 61: 145-154.